Biotechnology Insights | Page 2 of 5

3 ways to pandemic proof your facility

Segregation, cleanability, and automation/process closure are proven ways to protect viral containment through a pandemic and beyond.

Behind every rapid response is a strong regulatory strategy

During a global pandemic, the pharmaceutical industry must juggle the need for speed and the need to protect patient safety. A strong regulatory strategy makes it possible to accelerate drug development without getting slowed down by compliance considerations.

10 tips for operating construction sites during the COVID-19 pandemic

In the era of COVID-19, construction companies across America are trying to find the best way forward. There are a host of new challenges that every construction organization has to deal with.

During a crisis, moving drugs to market requires a strong HVAC strategy

As the global pandemic brings new attention to emerging therapies, the biopharmaceutical industry shouldn’t overlook HVAC design for contamination control.

6 considerations for scaling up an industrial biotechnology process

Industrial biotechnology processes face a unique set of challenges when it comes to scale-up.

Viral vectors—beyond the yellow brick road

The science of viral vector manufacturing is generating a lot of excitement, and companies in this space are under pressure to move fast and make cost-effective decisions; this can occasionally result in speed at the expense of due diligence.

Vaccines—our best long-term defense

Not a treatment, but a cure, vaccines are extremely important because they help us develop lifelong immunity to diseases.

Multimodal ATMP facilities to satisfy growing demand

Multimodal manufacturing optimizes product combinations based on manufacturing and regulatory similarity and compatibility. Manufacturers must produce a variety of Advanced Therapy Medicinal Products (ATMPs) quickly and efficiently. Why not design a multi-modal ATMP facility?

ATMP facilities: the cost of manufacturing a magic bullet

Essential strategies to position your ATMP facility for success.

COVID-19 drug development strategies

All eyes are on those on the front lines seeking to develop and produce new drugs. There’s unprecedented pressure to offer both immediate treatments for those affected and long-term biotherapies and vaccines to prevent future epidemics.

Biotechnology

Revolutionary insights for the next gen of medicine.